These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34362853)

  • 41. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
    Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
    [No Abstract]   [Full Text] [Related]  

  • 42. Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis.
    Lotan I; Billiet T; Ribbens A; Van Hecke W; Huang B; Kister I; Lotan E
    Mult Scler Relat Disord; 2023 Jan; 69():104436. PubMed ID: 36512956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRI differences between MOG antibody disease and AQP4 NMOSD.
    Salama S; Khan M; Shanechi A; Levy M; Izbudak I
    Mult Scler; 2020 Dec; 26(14):1854-1865. PubMed ID: 31937191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
    Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
    Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.
    Leite MI; Coutinho E; Lana-Peixoto M; Apostolos S; Waters P; Sato D; Melamud L; Marta M; Graham A; Spillane J; Villa AM; Callegaro D; Santos E; da Silva AM; Jarius S; Howard R; Nakashima I; Giovannoni G; Buckley C; Hilton-Jones D; Vincent A; Palace J
    Neurology; 2012 May; 78(20):1601-7. PubMed ID: 22551731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder.
    Lee MY; Yong KP; Hyun JW; Kim SH; Lee SH; Kim HJ
    Neurology; 2020 Dec; 95(23):e3124-e3128. PubMed ID: 32928976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
    Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
    CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pruritus in neuromyelitis optica spectrum disorders and multiple sclerosis.
    He M; Wu L; Huang D; Yau V; Yu S
    J Clin Neurosci; 2020 Sep; 79():108-112. PubMed ID: 33070876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
    Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
    Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis.
    Wang N; Zhang SN; Xing RJ; Liu MQ; Huang CN; Jiang SM; Li T; Yang CS; Yang L; Zhang LJ
    Mult Scler Relat Disord; 2021 Jan; 47():102629. PubMed ID: 33232908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
    Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
    [No Abstract]   [Full Text] [Related]  

  • 54. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
    Long Y; Chen M; Zhang B; Gao C; Zheng Y; Xie L; Gao Q; Yin J
    J Neuroimmunol; 2014 Apr; 269(1-2):62-7. PubMed ID: 24582827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
    Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
    Front Immunol; 2021; 12():647618. PubMed ID: 33796113
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder.
    Cai MT; Zheng Y; Shen CH; Yang F; Fang W; Zhang YX; Ding MP
    Mult Scler; 2021 May; 27(6):871-882. PubMed ID: 32672091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
    J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
    J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinalysis in patients with neuromyelitis optica spectrum disorder.
    Chen ZG; Huang J; Fan R; Weng RH; Shinohara RT; Landis JR; Chen Y; Jiang Y
    Eur J Neurol; 2020 Apr; 27(4):619-625. PubMed ID: 31729806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.